Minted: - / 5000

3639 Ponatinib
26a2556d3489246f560723d17657d92b5c861560f5f1f192144186026f776aa1

Properties

Background

Brown
Bottle

Blue
Cap

Purple
Syringe

Orange
Bubbles
No
Drops
No
Label
Cross

Chemistry

Formula
C29H27F3N6O
Carbon
29
Polarity
Neutral

Ponatinib (trade name Iclusig , previously AP24534) is an oral drug developed by ARIAD Pharmaceuticals for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia (ALL). It is a multi-targeted tyrosine-kinase inhibitor. Some forms of CML, those that have the T315I mutation, are resistant to current therapies such as imatinib. Ponatinib has been designed to be effective against these types of tumors.

From Wikipedia, the free encyclopedia. License: CC BY-SA.